Half-life-extended Monoclonal Antibody APG777 for Atopic Dermatitis: Design of the Phase 2 APEX Study. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s456. https://doi.org/10.25251/skin.8.supp.456